Search results for "Collagenase"

showing 10 items of 45 documents

Shed membrane vesicles and selective localization of gelatinases and MMP-9/TIMP-1 complexes.

1999

OrganellesGelatinasesTissue Inhibitor of Metalloproteinase-1ChemistryGeneral NeuroscienceBlotting WesternCell MembraneBreast NeoplasmsMatrix metalloproteinaseGeneral Biochemistry Genetics and Molecular BiologyCell biologyHistory and Philosophy of ScienceMatrix Metalloproteinase 9GelatinasesTumor Cells CulturedHumansMembrane vesicleFemaleCollagenCollagenasesProtein BindingAnnals of the New York Academy of Sciences
researchProduct

Collagenase-3 (MMP-13) Enhances Remodeling of Three-Dimensional Collagen and Promotes Survival of Human Skin Fibroblasts

2006

Collagenase-3 (MMP-13) is a matrix metalloproteinase capable of cleaving a multitude of extracellular matrix proteins in addition to fibrillar collagens. Human MMP-13 is expressed by fibroblasts in chronic cutaneous ulcers, but not in normally healing adult skin wounds. However, MMP-13 is produced by fibroblasts in adult gingival and in fetal skin wounds characterized by rapid collagen remodeling and scarless healing. Here, we have examined the role of human MMP-13 in remodeling of three-dimensional (3D) collagenous matrix by primary adult human skin fibroblasts. The high level of human MMP-13 expression by fibroblasts achieved by adenoviral gene delivery resulted in potent enhancement of r…

Pathologymedicine.medical_specialtyCell SurvivalHuman skinDermatologyMatrix Metalloproteinase InhibitorsMatrix metalloproteinaseBiologyBiochemistryFilamentous actinAdenoviridaeDermal fibroblastExtracellular matrixMatrix Metalloproteinase 13medicineHumansFibroblastMolecular BiologyCells CulturedCell ProliferationWound HealingTissue Inhibitor of Metalloproteinase-1integumentary systemCell BiologyFibroblastsActinsCell biologyEnzyme ActivationCollagen type I alpha 1medicine.anatomical_structureCollagenaseCollagenmedicine.drugJournal of Investigative Dermatology
researchProduct

Expression of osteopontin messenger RNA and protein in rheumatoid arthritis: Effects of osteopontin on the release of collagenase 1 from articular ch…

2000

Objective Osteopontin (OPN) is an extracellular matrix protein that has been implicated in the interactions between tumor cells and host matrix, including those involved in invasion and spread of tumor cells. Because joint destruction in rheumatoid arthritis (RA) is mediated by the invasive growth of synovial tissue through its attachment to cartilage, we examined the expression of OPN in the synovia of patients with RA and the effect of OPN on the production of collagenase 1 in rheumatoid synovial fibroblasts and articular chondrocytes. Methods The expression of OPN messenger RNA (mRNA) and protein in synovia from 10 RA patients was examined by in situ hybridization and immunohistochemistr…

Pathologymedicine.medical_specialtybiologyCartilageImmunologyMolecular biologyChondrocyteExtracellular matrixmedicine.anatomical_structurestomatognathic systemRheumatologybiology.proteinCollagenasemedicineImmunology and AllergyInterstitial collagenasePharmacology (medical)OsteopontinSynovial membraneFibroblastmedicine.drugArthritis & Rheumatism
researchProduct

AB0069 Conditioned media from adipose-derived mesenchymal stem cells decreases senescence and enhances collagen ii expression in osteoarthritic chond…

2013

Background Adipose-derived mesenchymal stem cells (ASC) might act as a cellular source of soluble factors exerting anti-inflammatory or trophic effects on cells. Osteoarthritis (OA) is characterized by the progressive loss of structure and functionality of articular cartilage. Objectives In the present study we explored the effect of conditioned medium from adipose-derived mesenchymal stem cells (ASC-CM) on the metabolism of OA chondrocytes in primary culture. Methods ADC were isolated from adipose tissue of patients subjected to abdominal lipectomy surgery, by collagenase treatment. Cells were incubated in DMEM/F12 + 15% human serum. Cell phenotype was analysed by flow cytometry with speci…

Pathologymedicine.medical_specialtymedicine.medical_treatmentImmunologyMesenchymal stem cellAdipose tissueInterleukinBiologyMatrix metalloproteinaseGeneral Biochemistry Genetics and Molecular BiologyAndrologyCell therapychemistry.chemical_compoundCytokineRheumatologychemistrymedicineCollagenaseImmunology and AllergyPropidium iodidemedicine.drugAnnals of the Rheumatic Diseases
researchProduct

Activation of the first component of complement, C1: comparison of the effect of sixteen different enzymes on serum C1.

1983

In this study, the effect of sixteen different enzymes on serum C1 and its subcomponents was investigated. The sixteen enzymes could be divided into three groups. First, enzymes which activate native C1: trypsin (optimal concentration 2.4 x 10(-4) mM); alpha-chymotrypsin (2.3 x 10(3) mM); thrombin (1.0 x 10(-5) mM); plasmin (1.9 x 10(-5) mM); elastase (5.8 x 10(-5) mM); pronase (3.0 x 10(-6) mM). All these enzymes are serine esterase and activate native serum C1 bound to EAC4 at the given concentration within 10 min at 30 degrees C. Furthermore, native C1 inhibited by a pentosanpolysulfoester, Sp54, is unable to undergo the internal activation but can be externally activated by the serine e…

PlasminComplement Activating EnzymesImmunologyGuinea PigsDose-Response Relationship ImmunologicPronaseSerinechemistry.chemical_compoundComplement C1medicineImmunology and AllergyAnimalsHumansTrypsinFibrinolysinComplement Activationchemistry.chemical_classificationPentosan Sulfuric PolyesterbiologyHematologyTrypsinCarboxypeptidaseKineticsEnzymeBiochemistrychemistrybiology.proteinCollagenaseCattleRabbitsLysozymemedicine.drugPeptide HydrolasesImmunobiology
researchProduct

SPIONs embedded in polyamino acid nanogels to synergistically treat tumor microenvironment and breast cancer cells.

2018

Abstract The extremely complex tumor microenvironment (TME) in humans is the major responsible for the therapeutic failure in cancer nanomedicine. A new concept of disease-driven nanomedicine, henceforth named “Theranomics”, which attempts to target cancer cells and TME on the whole, represents an attractive alternative. Herein, a nanomedicine able to co-deliver doxorubicin and a tumor suppressive proteolytic protein such as collagenase-2 was developed. We successfully obtained superparamagnetic nanogels (SPIONs/Doco@Col) via the intermolecular azide-alkyne Huisgen cycloaddition. We demonstrated that a local ECM degradation and remodeling in solid tumors by means of collagenase-2 could enha…

Polyamino acidPolyamino acidsCollagenasePharmaceutical ScienceBreast Neoplasms02 engineering and technology030226 pharmacology & pharmacy03 medical and health sciences0302 clinical medicineBreast cancerBreast cancerDrug Delivery SystemsCell Line TumormedicineTumor MicroenvironmentHumansDoxorubicinTargeted cancer therapyAmino AcidsMagnetite NanoparticlesTumor microenvironmentAntibiotics AntineoplasticChemistrySPIONCancerTheranomicDrug Synergism021001 nanoscience & nanotechnologymedicine.diseasenanomedicineNanomedicinesDrug LiberationSPIONsMatrix Metalloproteinase 8DoxorubicinCancer cellCancer researchNanomedicineTheranomicsFemaleBreast cancer cellspolyamino acid0210 nano-technologyGelsmedicine.drugInternational journal of pharmaceutics
researchProduct

A new method to value efficiency of enzyme blends for pancreas tissue digestion

2010

In pancreatic islets isolation for cell therapy the major enzymes used are obtained from Clostridium hystoliticum: class I and class II collagenases. They are used in a defined tissue dissociation enzyme mixture together with neutral protease (Dispase) or thermolysin (Thermostable Neutral Protease). However, just to now, people working in islets production found variable outcomes in isolation procedures mainly due to large variability in enzymatic blend composition and efficacy. Using electrophoresis and gelatin zymography approaches together with densitometry evaluation assays we compared the composition, stability and auto-digestion processes of C. hystoliticum collagenases, Neutral prote…

Settore BIO/10 - BiochimicaPancreatic enzyme cell therapy collagenases.
researchProduct

C. HYSTOLITICUM RECOMBINANT COLLAGENASES AND METHOD FOR THE MANUFACTURE THEREOF

2010

The present invention relates to the production of recombinant collagenases, and in particular describes a method for the production of recombinant clostridium histolyticum collagenases Col characterized by a yield higher than approximately 140 mg/l of culture of said collagenases in soluble, biologically active form, collagenases produced by this method, compositions comprising these collagenases and the use thereof.

Settore BIO/13 - Biologia ApplicataCOLLAGENASESSettore BIO/10 - BiochimicaCELL TERAPYDIABET 1RECOMBINANT PROTEIN
researchProduct

Synthesis and degradation of type IV collagen in rat skeletal muscle during immobilization in shortened and lengthened positions

2003

Aim:  Type IV collagen is a major protein in basement membranes surrounding and supporting skeletal muscle cells. In the present study, we tested the hypotheses that immobilization down-regulates synthesis and up-regulates degradation of type IV collagen in skeletal muscle. Methods:  mRNA level and concentration of type IV collagen as well as mRNA levels and activities of proteins involved in its degradation were analysed from soleus (SOL), gastrocnemius (GAS) and extensor digitorum longus muscles after immobilization in shortened and lengthened positions for 1, 3 and 7 days. Results:  Following immobilization, type IV collagen mRNA level was decreased in SOL and GAS suggesting down-regulat…

Soleus musclemedicine.medical_specialtyPhysiologyChemistrySkeletal muscleMatrix (biology)Extracellular matrixExtensor digitorum muscleType IV collagenGastrocnemius musclemedicine.anatomical_structureEndocrinologyBiochemistryInternal medicinemedicineCollagenasemedicine.drugActa Physiologica Scandinavica
researchProduct

Activation of complement by the alternative pathway as a factor in the pathogenesis of periodontal disease.

1976

Dental plaque and a bacterium, Actinomyces viscosus, isolated from plaque that can reproduce periodontal disease in germ-free rats, are activators of complement by the alternative pathway. It is suggested that this process is involved in the pathogenesis of chronic inflammatory periodontal disease.

T-LymphocytesGuinea PigsDental PlaqueAntigen-Antibody ComplexDental plaquePathogenesisstomatognathic systemPeriodontal diseasemedicineActinomycesAnimalsHumansActinomyces viscosusBone ResorptionPeriodontitisGlycoproteinsB-LymphocytesEnzyme Precursorsbusiness.industryMacrophagesGlobulinsGeneral MedicineComplement C3Complement System Proteinsmedicine.diseaseCathepsinsComplement (complexity)RatsEndotoxinsstomatognathic diseasesMicrobial CollagenaseImmunologyAlternative complement pathwaybusinessLancet (London, England)
researchProduct